Scales and questionnaires for the diagnosis of Dupuytren’s disease

Authors

  • German V. Medvedev Russian Scientific Research Institute of Traumatology and Orthopedics named after R. R. Vreden, 8, ul. Akademika Baykova, St. Petersburg, 195427, Russian Federation
  • Denis Pushkin St. Petersburg State University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation https://orcid.org/0000-0001-7390-1609
  • Artem Orlov Pavlov First St. Petersburg State Medical University, 6–8, ul. L’va Tolstogo, St. Petersburg, 197022, Russian Federation https://orcid.org/0000-0002-5996-3405
  • Artem Petrov Krasnoyarsk State Medical University, 1, ul. Partizana Zheleznyaka, Krasnoyarsk, 660022, Russian Federation https://orcid.org/0000-0003-2757-4875
  • Lyubov Rodomanova Russian Scientific Research Institute of Traumatology and Orthopedics named after R. R. Vreden, 8, ul. Akademika Baykova, St. Petersburg, 195427, Russian Federation;Pavlov First St. Petersburg State Medical University, 6–8, ul. L’va Tolstogo, St. Petersburg, 197022, Russian Federation
  • Yaroslav Proshchenko National Medical Research Center for Pediatric Traumatology and Orthopedics named after G. I. Turner, 64–68, ul. Parkovaya, Pushkin, St. Petersburg, 196603, Russian Federation

DOI:

https://doi.org/10.21638/spbu11.2024.102

Abstract

Dupuytren’s disease is a multifactorial polygenic disease accompanied by hand deformity with
flexion contracture of the fingers. Despite the improvement of surgical treatment methods for
this disease, the rate of postoperative relapses is high and can reach a third of cases or more.
A search of scientific literature in databases was conducted using keywords and their combinations
to analyze and systematize methodological approaches to the use of scales and questionnaires
for patients with Dupuytren’s disease. 28 scales and questionnaires were found and analyzed, but only 11 of them correspond to the purpose of this study and can be recommended for use in real clinical practice. We divided these scales into four groups. Many diagnostic scales and questionnaires, on the one hand, expands the capabilities of the orthopedic traumatologist in diagnosing and assessing the dynamics of disease progression, but on the other
hand, each of the analyzed scales separately does not make it possible to comprehensively assess the associated parameters. At the same time, the use of several scales on an outpatient basis and in a 24-hour hospital setting takes quite a lot of time.

Keywords:

Dupuytren’s disease, Dupuytren’s contracture, fibrosis of the palmar aponeurosis, palmar fascial fibromatosis, palmar fibroma, scale, questionnaire

Downloads

Download data is not yet available.
 

References

Литература

Childs S. G. Dupuytren’s disease // Orthop. Nurs. 2005. Vol. 24, no. 2. P. 160–163. https://doi.org/10.1097/00006416-200503000-00014

Loos B., Puschkin V., Horch R. E. 50 years experience with Dupuytren’s contracture in the Erlangen University Hospital — a retrospective analysis of 2919 operated hands from 1956 to 2006 // BMC Musculoskelet. Disord. 2007. Vol. 8, no. 60. https://doi.org/10.1186/1471-2474-8-60

Kilian O., Pfeil U., Wenisch S., Kraus R., Schnettler R. Enhanced alpha 1(I) mRNA expression in frozen shoulder and Dupuytren tissue // Eur. J. Med. Res. 2007. Vol. 12, no. 12. P. 585–590.

Thurston A. J. Dupuytren’s disease // J. Bone Joint Surg. Br., 2003. Vol. 85, no. 4. P. 469–477. https://doi.org/10.1302/0301-620X. 85B4.14215

Townley W. A., Baker R., Sheppard N., Grobbelaar A. O. Dupuytren’s contracture unfolded // BMJ. 2006.Vol. 332, no. 7538. P. 397–400. https://doi.org/10.1136/BMJ. 332.7538.397

Микусев Г. И., Магомедов P. O., Осмоналиев И. Ж., Байкеев Р. Ф., Микусев И. Е. Контрактура Дюпюитрена: эпидемиология, этиология, патогенез, диагностика и лечение // Казанскиймедицинский журнал. 2011. Т. 92, № 6. С. 896–900.

Руцкий В. В., Ермаков А. Н. Достижение и нерешенные вопросы в лечении контрактуры Дюпюитрена // Вестник хирургии. 1986. Т. 4. С. 157.

Микусев Г. И., Байкеев Р. Ф., Микусев И. Е., Магомедов Р. О. Болезнь Дюпюитрена. Регистр по РТ// Вестник травматологии и ортопедии им. Н. Н. Приорова. 2007. Т. 4. С. 65–69.

Ayala F. J., Escalante A. A. The evolution of human populations: A molecular perspective // Mol. Phylogenet.Evol. 1996. Vol. 5, no. 1. P. 188–201. https://doi.org/10.1006/MPEV.1996.0013

Samulenas G., Insodaite R., Kunceviciene E., Poceviciute R., Masionyte L., Zitkeviciute U., Pilipaityte L., Smalinskiene A. The Role of Functional Polymorphisms in the Extracellular Matrix Modulation-Related Genes on Dupuytren’s Contracture // Genes (Basel). 2022. Vol. 13, no. 5. P. 743. https://doi.org/10.3390/genes13050743

Trybus M., Bednarek M., Lorkowski J., Teul I. Psychologic aspects of Dupuytren’s disease: a new scale of subjective well-being of patients // Ann. Acad. Med. Stetin. 2011. Vol. 57, no. 1. P. 31–37.

Ware J. E., Sherbourne C. D. The MOS 36-item short-form health survey (Sf-36): I. conceptual framework and item selection // Med. Care. 1992. Vol. 30, no. 6. P. 473–483. https://doi.org/10.1097/00005650-199206000-00002

Abe Y., Rokkaku T., Ofuchi S., Tokunaga S., Takahashi K., Moriya H. An objective method to evaluate the risk of recurrence and extension of Dupuytren’s disease // J. Hand Surg. Br. 2004. Vol. 29, no. 5.P. 427–430. https://doi.org/10.1016/j.jhsb.2004.06.004

Morelli I., Fraschini G., Banfi A. E. Dupuytren’s Disease: Predicting Factors and Associated Conditions. A Single Center Questionnaire-Based Case-Control Study // Arch. Bone Jt. Surg. 2017. Vol. 5, no. 6.P. 384. https://doi.org/10.22038/abjs.2017.21022.1542

White J. W., Kang S. N., Nancoo T., Floyd D., Kambhampati S. B. S., McGrouther D. A. Management of severe Dupuytren’s contracture of the proximal interphalangeal joint with use of a central slip facilitation device // J. Hand Surg. (Eur. Vol.). 2012. Vol. 37, no. 8. P. 728–732.

Descatha A., Bodin J., Ha C., Goubault P., Lebreton M., Chastang J. F., Imbernon E., Leclerc A., Goldberg M., Roquelaure Y. Heavy manual work, exposure to vibration and Dupuytren’s disease? Results of a surveillance program for musculoskeletal disorders // Occup. Environ. Med. 2012. Vol. 69, no. 4.P. 296–299. https://doi.org/10.1136/oemed-2011-100319

Becker K., Tinschert S., Lienert A., Bleuler P. E., Staub F., Meinel A., Rößler J., Wach W., Hoffmann R., Kühnel F., Damert H. G., Nick H. E., Spicher R., Lenze W., Langer M., Nürnberg P., Hennies H. C. The importance of genetic susceptibility in Dupuytren’s disease // Clin Genet. 2015. Vol. 87, no. 5. P. 483–487.https://doi.org/10.1111/cge.12410

Mohan A., Vadher J., Ismail H., Warwick D. The Southampton Dupuytren’s scoring scheme // J. Plast.Surg. Hand Surg. 2014. Vol. 48, no. 1. P. 28–33. https://doi.org/10.3109/2000656X. 2013.794349

Beaudreuil J., Allard A., Zerkak D., Gerber R. A., Cappelleri J. C., Quintero N., Lasbleiz S., Bernabé B.,Orcel P., Bardin T. Unité Rhumatologique des Affections de la Main (URAM) scale: Development and validation of a tool to assess Dupuytren’s disease-specific disability // Arthritis Care Res. 2011. Vol. 63,no. 10. P. 1448–1455. https://doi.org/10.1002/ACR. 20564

Hudak P. L., Amadio P. C., Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG) // Am. J. Ind. Med. 1996. Vol. 29, no. 6. P. 602–608. https://doi.org/10.1002/(sici)1097-0274(199606)29:6<602::aid-ajim4>3.0.co;2-l

Van Kooij Y. E., Poelstra R., Porsius J. T., Slijper H. P., Warwick D., Selles R. W. Content validity and responsiveness of the Patient-Specific Functional Scale in Patients with Dupuytren’s disease // J. Hand Ther. 2021. Vol. 34, no. 3. P. 446–452. https://doi.org/10.1016/j.jht.2020.03.009

Chung K. C., Pillsbury M. S., Walters M. R., Hayward R. A. Reliability and validity testing of the Michigan Hand Outcomes Questionnaire // J. Hand Surg. Am. 1998. Vol. 23, no. 4. P. 575–587. https://doi.org/10.1016/S0363-5023(98)80042-7

Thoma A., Kaur M. N., Ignacy T. A., Levis C., Martin S., Duku E., Haines T. Health-related quality of life in patients undergoing palmar fasciectomy for Dupuytren’s disease // Plast. Reconstr. Surg. 2014.Vol. 133, no. 6. P. 1411–1419. https://doi.org/10.1097/PRS. 0000000000000177

Rodrigues J., Zhang W., Scammell B., Russell P., Chakrabarti I., Fullilove S., Davidson D., Davis T. Validity of the Disabilities of the Arm, Shoulder and Hand patient-reported outcome measure (DASH) and the Quickdash when used in Dupuytren’s disease // J. Hand Surg. (Eur. Vol.). 2016. Vol. 41, no. 6.P. 589–599. https://doi.org/10.1177/1753193415601350

Poelstra R., van Kooij Y. E., van der Oest M. J. W., Slijper H. P., Hovius S. E. R., Selles R. W. Patient’s satisfaction beyond hand function in Dupuytren’s disease: analysis of 1106 patients // J. Hand Surg. Eur.2020. Vol. 45, no. 3. P. 280–285. https://doi.org/10.1177/1753193419890284

Van den Berge B. A., Blom P. C. A., Werker P. M. N., Broekstra D. C. Patient-Perceived Hand Function Can Predict Treatment for Dupuytren Disease // Plast. Reconstr. Surg. 2023. Vol. 152, no. 5. P. 867e–875e. https://doi.org/10.1097/PRS. 0000000000010515


References

Childs S. G. Dupuytren’s disease. Orthop. Nurs.,2005, vol. 24, no. 2, pp. 160–163. https://doi.org/10.1097/00006416-200503000-00014

Loos B., Puschkin V., Horch R. E. 50 years experience with Dupuytren’s contracture in the Erlangen University Hospital — a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet.Disord., 2007, vol. 8, no. 60. https://doi.org/10.1186/1471-2474-8-60

Kilian O., Pfeil U., Wenisch S., Kraus R., Schnettler R. Enhanced alpha 1(I) mRNA expression in frozen shoulder and Dupuytren tissue. . Eur. J. Med. Res., . 2007, vol. 12, no. 12, pp. 585–590.

Thurston A. J. Dupuytren’s disease. J. Bone Joint Surg. Br., 2003, vol. 85, no. 4, pp. 469–477. https://doi.org/10.1302/0301-620X. 85B4.14215

Townley W. A., Baker R., Sheppard N., Grobbelaar A. O. Dupuytren’s contracture unfolded. BMJ, 2006,vol. 332, no. 7538, pp. 397–400. https://doi.org/10.1136/BMJ.332.7538.397

Epidemiology, etiology, pathogenesis, diagnosis and treatment. Kazanskii meditsinskii zhurnal,2011, vol. 92, no. 6, pp. 896–900. (In Russian)

Rutsky V. V., Ermakov A. N. Achievements and unresolved issues in the treatment of Dupuytren’s contracture.Vestnik khirurgii, 1986, vol. 4, p. 157. (In Russian)

Mikusev G. I., Baikeev R. F., Mikusev I. E., Magomedov R. O. Dupuytren’s disease. Register for the Republic of Tatarstan. Vestnik travmatologii i ortopedii imeni N. N. Priorova, 2007, vol. 4, pp. 65–69. (In Russian)

Ayala F. J., Escalante A. A. The evolution of human populations: A molecular perspective. Mol. Phylogenet.Evol., 1996, vol. 5, no. 1, pp. 188–201. https://doi.org/10.1006/MPEV. 1996.0013

Samulenas G., Insodaite R., Kunceviciene E., Poceviciute R., Masionyte L., Zitkeviciute U., Pilipaityte L.,Smalinskiene A. The Role of Functional Polymorphisms in the Extracellular Matrix Modulation-Related Genes on Dupuytren’s Contracture. Genes (Basel), 2022, vol. 13, no. 5, p. 743. https://doi.org/10.3390/genes13050743

Trybus M., Bednarek M., Lorkowski J., Teul I. Psychologic aspects of Dupuytren’s disease: A new scale of subjective well-being of patients. Ann. Acad. Med. Stetin,/ 2011, vol. 57, no. 1, pp. 31–37.

Ware J. E., Sherbourne C. D. The MOS 36-item short-form health survey (Sf-36): I. conceptual framework and item selection. Med. Care, 1992, vol. 30, no. 6, pp. 473–483. https://doi.org/10.1097/00005650-199206000-00002

Abe Y., Rokkaku T., Ofuchi S., Tokunaga S., Takahashi K., Moriya H. An objective method to evaluate the risk of recurrence and extension of Dupuytren’s disease. J. Hand Surg. Br., 2004, vol. 29, no. 5,pp. 427–430. https://doi.org/10.1016/j.jhsb.2004.06.004

Morelli I., Fraschini G., Banfi A. E. Dupuytren’s Disease: Predicting Factors and Associated Conditions. A Single Center Questionnaire-Based Case ControlStudy.Arch. Bone Jt. Surg.,/ 2017, vol. 5,no. 6, pp. 384. https://doi.org/10.22038/abjs.2017.21022.1542

White J. W., Kang S. N., Nancoo T., Floyd D., Kambhampati S. B. S., McGrouther D. A. Management of severe Dupuytren’s contracture of the proximal interphalangeal joint with use of a central slip facilitation device. J. Hand Surg. (Eur. Vol.), 2012, vol. 37, no. 8, pp. 728–732.

Descatha A., Bodin J., Ha C., Goubault P., Lebreton M., Chastang J. F., Imbernon E., Leclerc A., Goldberg M., Roquelaure Y. Heavy manual work, exposure to vibration and Dupuytren’s disease? Results of a surveillance program for musculoskeletal disorders. Occup. Environ. Med.,/ 2012, vol. 69, no. 4,pp. 296–299. https://doi.org/10.1136/oemed-2011-100319

Becker K., Tinschert S., Lienert A., Bleuler P. E., Staub F., Meinel A., Rößler J., Wach W., Hoffmann R.,Kühnel F., Damert H. G., Nick H. E., Spicher R., Lenze W., Langer M., Nürnberg P., Hennies H. C. The importance of genetic susceptibility in Dupuytren’s disease. Clin. Genet., 2015, vol. 87, no. 5, pp. 483–487. https://doi.org/10.1111/cge.12410

Mohan A., Vadher J., Ismail H., Warwick D. The Southampton Dupuytren’s scoring scheme. . J. Plast.Surg. Hand Surg. . 2014, vol. 48, no. 1, pp. 28–33. https://doi.org/10.3109/2000656X.2013.794349

Beaudreuil J., Allard A., Zerkak D., Gerber R. A., Cappelleri J. C., Quintero N., Lasbleiz S., Bernabé B.,Orcel P., Bardin T. Unité Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren’s disease-specific disability. Arthritis Care Res., 2011, vol. 63,no. 10, pp. 1448–1455. https://doi.org/10.1002/ACR. 20564

Hudak P. L., Amadio P. C., Bombardier C. Development of an upper extremity outcome measure: The DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am. J. Ind. Med., 1996, vol. 29, no. 6, pp. 602–608. https://doi.org/10.1002/(sici)1097- 0274(199606)29:6<602::aid -ajim4>3.0.co;2-l

Van Kooij Y. E., Poelstra R., Porsius J. T., Slijper H. P., Warwick D., Selles R. W. Content validity and responsiveness of the Patient-Specific Functional Scale in Patients with Dupuytren’s disease. J. Hand Ther., 2021, vol. 34, no. 3, pp. 446–452. https://doi.org/10.1016/j.jht.2020.03.009

Chung K. C., Pillsbury M. S., Walters M. R., Hayward R. A. Reliability and validity testing of the Michigan Hand Outcomes Questionnaire. J. Hand Surg. Am., 1998, vol. 23, no. 4, pp. 575–587. https://doi.org/10.1016/S0363-5023(98)80042-7

Thoma A., Kaur M. N., Ignacy T. A., Levis C., Martin S., Duku E., Haines T. Health-related quality of life in patients undergoing palmar fasciectomy for Dupuytren’s disease. Plast. Reconstr. Surg., 2014,vol. 133, no. 6, pp. 1411–1419. https://doi.org/10.1097/PRS.0000000000000177

Rodrigues J., Zhang W., Scammell B., Russell P., Chakrabarti I., Fullilove S., Davidson D., Davis T. Validity of the Disabilities of the Arm, Shoulder and Hand patient-reported outcome measure (DASH) and the Quickdash when used in Dupuytren’s disease. J. Hand Surg. Eur., 2016, vol. 41, no. 6, pp. 589–599. https://doi.org/10.1177/1753193415601350

Poelstra R., van Kooij Y. E., van der Oest M. J. W., Slijper H. P., Hovius S. E. R., Selles R. W. Patient’s satisfaction beyond hand function in Dupuytren’s disease: analysis of 1106 patients. J. Hand Surg.(Eur. Vol.), 2020, vol. 45, no. 3, pp. 280–285. https://doi.org/10.1177/1753193419890284

Van den Berge B. A., Blom P. C. A., Werker P. M. N., Broekstra D. C. Patient-Perceived Hand Function Can Predict Treatment for Dupuytren Disease. Plast. Reconstr. Surg., 2023, vol. 152, no. 5, pp. 867e–875e. https://doi.org/10.1097/PRS.0000000000010515

Downloads

Published

2024-08-26

How to Cite

Medvedev, G. V., Pushkin, D., Orlov , A., Petrov, A., Rodomanova , L., & Proshchenko, Y. (2024). Scales and questionnaires for the diagnosis of Dupuytren’s disease. Vestnik of Saint Petersburg University. Medicine, 19(1), 14–27. https://doi.org/10.21638/spbu11.2024.102

Issue

Vol. 19 No. 1 (2024)

Section

Surgery

License

Articles of "Vestnik of Saint Petersburg University. Medicine" are open access distributed under the terms of the License Agreement with Saint Petersburg State University, which permits to the authors unrestricted distribution and self-archiving free of charge.